CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc. (NASDAQ: DMPI) - Sept Update

Sep 26, 2017, 02:00 PM

CEO Jeffrey Bacha of DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) returns to Stock Day to discuss finding new drug therapies and current clinical trials.

(NASDAQ: DMPI) # DelMar Pharmaceuticals # VAL-083 # MGMT # Clinical Trials # Drug Research # Phase 3 Clinical Trial

Subscribe
Next
CEO John Sprovieri of Auscrete Corporation (OTCPink: ASCK) - Sept Update
Top Episodes